The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Δημοσίευση

"Holidays" for osteoporosis drugs: A case-based approach.

Title"Holidays" for osteoporosis drugs: A case-based approach.
Publication TypeJournal Article
Year of Publication2019
AuthorsAnagnostis, P., Paschou S. A., Kenanidis E., Lambrinoudaki I., Potoupnis M., Tsiridis E., & Goulis D. G.
JournalCase Rep Womens Health
Volume23
Paginatione00127
Date Published2019 Jul
ISSN2214-9112
Abstract

•A "drug holiday" can be considered for patients at low fracture risk•It is optimal after completion of five years of alendronate and three years of zoledronic acid or risedronate use•The "drug holiday" strategy should not be implemented for denosumab, estrogen, SERMs or teriparatide.

DOI10.1016/j.crwh.2019.e00127
Alternate JournalCase Rep Womens Health
PubMed ID31431887
PubMed Central IDPMC6580330

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.